دورية أكاديمية

Effects of rasagiline combined with levodopa and benserazide hydrochloride on motor function and homocysteine and IGF-1 levels in elderly patients with Parkinson’s disease

التفاصيل البيبلوغرافية
العنوان: Effects of rasagiline combined with levodopa and benserazide hydrochloride on motor function and homocysteine and IGF-1 levels in elderly patients with Parkinson’s disease
المؤلفون: Yifan Yang, Feng Gao, Li Gao, Jiaodan Miao
المصدر: BMC Neurology, Vol 23, Iss 1, Pp 1-7 (2023)
بيانات النشر: BMC, 2023.
سنة النشر: 2023
المجموعة: LCC:Neurology. Diseases of the nervous system
مصطلحات موضوعية: Parkinson’ s disease, Levodopa and benserazide hydrochloride, Rasagiline, Hcy, IGF-1, Motor function, Neurology. Diseases of the nervous system, RC346-429
الوصف: Abstract Background During the course of their illness, people with Parkinson’s disease may see changes in their insulin-like growth factor (IGF-1) and serum homocysteine (Hcy) indices. In this study, patients with intermediate to severe Parkinson’s disease were examined for how Resagiline and levodopa and benserazide hydrochloride affected their motor performance, serum levels of homocysteine (Hcy), and insulin-like growth factor (IGF-1). Methods From June 2020 to December 2021, a total of 100+ cases of Parkinson’s patients over 60 years old in the middle and late stages of Parkinson’s were seen in the outpatient and inpatient departments of the Third People’s Hospital of Chengdu City and had a detailed observation record, and according to the inclusion criteria, the patients who met the criteria were randomly grouped into a clinical observation group and a control group. The subjects in the control group received only levodopa and benserazide hydrochloride treatment, while the observation group was treated with Resagiline in combination with the clinical control group. The total treatment observation period was 1 year for both groups, and the motor function and serum Hcy and IGF-1 indexes of both groups were compared after the end of treatment. Results We randomly and evenly grouped 64 patients who met the requirements of the inclusion criteria into a clinical observation group and a control group, each with 32 patients, from among 168 patients over 60 years of age with detailed observation records in the middle and late stages of Parkinson’s. After the 1-year observation period, we found that the total effective rate after treatment in the clinical observation group (93.75%) and significantly higher than that in the control group (68.75%) (P
نوع الوثيقة: article
وصف الملف: electronic resource
اللغة: English
تدمد: 1471-2377
Relation: https://doaj.org/toc/1471-2377
DOI: 10.1186/s12883-023-03411-3
URL الوصول: https://doaj.org/article/6d23c43f2b5a4dd7bc16b52560cf0eba
رقم الأكسشن: edsdoj.6d23c43f2b5a4dd7bc16b52560cf0eba
قاعدة البيانات: Directory of Open Access Journals
الوصف
تدمد:14712377
DOI:10.1186/s12883-023-03411-3